Fundraising FoxBiocartis
Mechelen, BE · 5 known investors
Find your way into Biocartis
Sign up to see every warm intro you have to Biocartis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biocartis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biocartis develops molecular diagnostic testing systems for cancer, with a focus on enabling personalized medicine through rapid, in-house biomarker analysis. The company's Idylla Platform automates molecular testing to help clinicians and patients access treatment information quickly.
Investors · 5
How we know: Advent Life Sciences's portfolio page · Not right? Tell us
How we know: New Rhein Healthcare Investors, LLC's portfolio page · Not right? Tell us
How we know: PMV's portfolio page · funding news · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountinitial public offeringApr 2015
Aescap (lead)
Source ↗ - Undisclosed amountIPOApr 2015Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Biocartis do?
- Biocartis develops molecular diagnostic testing systems for cancer, with a focus on enabling personalized medicine through rapid, in-house biomarker analysis. The company's Idylla Platform automates molecular testing to help clinicians and patients access treatment information quickly.
- Who are Biocartis's investors?
- Biocartis's investors include Advent Life Sciences, Korys, New Rhein Healthcare Investors, LLC, PMV.
- Where is Biocartis headquartered?
- Biocartis is headquartered in Mechelen, BE.